4.6 Article

Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 21, Pages 18614-18622

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.200881

Keywords

-

Funding

  1. Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus) [01GS0850, 01GS0851, 01GS0852, 01GS0868, 01GS0869, 01GS0853, 01GS0854]
  2. European Union (German Mouse Clinic) [EUMODIC LSHG-2006037188]

Ask authors/readers for more resources

ADAR2, an RNA editing enzyme that converts specific adenosines to inosines in certain pre-mRNAs, often leading to amino acid substitutions in the encoded proteins, is mainly expressed in brain. Of all ADAR2-mediated edits, a single one in the pre-mRNA of the AMPA receptor subunit GluA2 is essential for survival. Hence, early postnatal death of mice lacking ADAR2 is averted when the critical edit is engineered into both GluA2 encoding Gria2 alleles. Adar2(-/-)/Gria2(R/R) mice display normal appearance and life span, but the general phenotypic effects of global lack of ADAR2 have remained unexplored. Here we have employed the Adar2(-/-)/Gria2(R/R) mouse line, and Gria2(R/R) mice as controls, to study the phenotypic consequences of loss of all ADAR2-mediated edits except the critical one in GluA2. Our extended phenotypic analysis covering similar to 320 parameters identified significant changes related to absence of ADAR2 in behavior, hearing ability, allergy parameters and transcript profiles of brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available